Beliefs Among Pulmonologists and Thoracic Surgeons in the Therapeutic Approach to Non-small Cell Lung Cancer
The physicians who initially evaluate patients with non-small cell lung cancer (NSCLC) strongly impact the course of therapy. Their beliefs in treatment and prognosis may contribute to practices of variable quality and appropriateness. We sought to better describe beliefs among pulmonologists and th...
Gespeichert in:
Veröffentlicht in: | Chest 2000-07, Vol.118 (1), p.129-137 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 137 |
---|---|
container_issue | 1 |
container_start_page | 129 |
container_title | Chest |
container_volume | 118 |
creator | Schroen, Anneke T. Detterbeck, Frank C. Crawford, Robert Rivera, M. Patricia Socinski, Mark A. |
description | The physicians who initially evaluate patients with non-small cell lung cancer (NSCLC) strongly impact the course of therapy. Their beliefs in treatment and prognosis may contribute to practices of variable quality and appropriateness. We sought to better describe beliefs among pulmonologists and thoracic surgeons who were selected for guiding early therapy and referrals in patients with NSCLC.
Mail questionnaire focusing on survival estimates, treatment perceptions, and referral patterns.
Twelve hundred pulmonologists and 800 thoracic surgeons who were clinically active members of the American College of Chest Physicians.
Response rates of 50% for pulmonologists and 52% for thoracic surgeons were obtained after two mailings. Five-year survival estimates for patients with resected stage I NSCLC revealed that 30% of respondents overestimated survival rates and 18% underestimated survival rates. The underestimation of survival rate was found among more respondents who are practicing pulmonology than thoracic surgery (22% vs 0.10%, respectively), who were trained before 1980 than after 1980 (29% vs 0.10%, respectively), and who were seeing < 10 lung cancer patients annually than those who were seeing > 25 (31% vs 0.14%, respectively). Beliefs in the survival benefit of adjuvant chemotherapy or of radiation in stage I-IIIA disease divided respondents within both specialties. Chemotherapy plus radiation vs radiation alone in unresectable stage IIIA-B NSCLC was viewed as benefiting survival less often by physicians seeing < 10 lung cancer patients annually rather than > 25 (57% vs 0.77%, respectively) and by physicians underestimating rather than correctly estimating survival in early-stage disease (58% vs 0.72%, respectively). Chemotherapy was believed to confer survival benefits in patients with stage IV disease by one third of respondents.
Certain physician characteristics, particularly the length of time since training and NSCLC patient volume, are associated with beliefs not conclusively supported in the medical literature or with opinions inconsistent within and between specialties. |
doi_str_mv | 10.1378/chest.118.1.129 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71232429</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0012369215390139</els_id><sourcerecordid>71232429</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-58084f57560469b7b66e970ab88789407586274bdb00f5c8125d7e96e677f9833</originalsourceid><addsrcrecordid>eNp1kd-L1DAQx4Mo3nr67JsEkXvrXtK0-fG4t3gqLCp4Poc0nW5zdJs1aRX_e8ftwh2CLxnCfOY7X75DyGvO1lwofe17yNOac73ma16aJ2TFjeCFqCvxlKwY42UhpCkvyIuc7xn-uZHPyQVn2gih2IoMNzAE6DLdHOK4p1_nAWsc4j7kKVM3tvSuj8n54Om3Oe0hjpmGkU49YAOSO8I8YW9zPKbofE-nSD_HscgHNwx0C_jsZtTdutFDekmedW7I8OpcL8n32_d324_F7suHT9vNrvCVMFNRa6arrla1ZJU0jWqkBKOYa7RW2lRM1VqWqmrahrGu9pqXdavASJBKdUYLcUmuFl009WPGhOwhZI9m3AhxzlbxUpRVaRB8-w94H-c0ojdbMlYpXCgRul4gn2LOCTp7TOHg0m_Lmf17BXu6gsUrWG75SfbNWXZuDtA-4pfYEXh3Blz2bugSxhPyA1cJKQV72NyHff8rJLCnXFFVLDvPbh9vNssEYLw_AySbfQDMvsVpP9k2hv-6_gOxZ7Nq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200478876</pqid></control><display><type>article</type><title>Beliefs Among Pulmonologists and Thoracic Surgeons in the Therapeutic Approach to Non-small Cell Lung Cancer</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Schroen, Anneke T. ; Detterbeck, Frank C. ; Crawford, Robert ; Rivera, M. Patricia ; Socinski, Mark A.</creator><creatorcontrib>Schroen, Anneke T. ; Detterbeck, Frank C. ; Crawford, Robert ; Rivera, M. Patricia ; Socinski, Mark A.</creatorcontrib><description>The physicians who initially evaluate patients with non-small cell lung cancer (NSCLC) strongly impact the course of therapy. Their beliefs in treatment and prognosis may contribute to practices of variable quality and appropriateness. We sought to better describe beliefs among pulmonologists and thoracic surgeons who were selected for guiding early therapy and referrals in patients with NSCLC.
Mail questionnaire focusing on survival estimates, treatment perceptions, and referral patterns.
Twelve hundred pulmonologists and 800 thoracic surgeons who were clinically active members of the American College of Chest Physicians.
Response rates of 50% for pulmonologists and 52% for thoracic surgeons were obtained after two mailings. Five-year survival estimates for patients with resected stage I NSCLC revealed that 30% of respondents overestimated survival rates and 18% underestimated survival rates. The underestimation of survival rate was found among more respondents who are practicing pulmonology than thoracic surgery (22% vs 0.10%, respectively), who were trained before 1980 than after 1980 (29% vs 0.10%, respectively), and who were seeing < 10 lung cancer patients annually than those who were seeing > 25 (31% vs 0.14%, respectively). Beliefs in the survival benefit of adjuvant chemotherapy or of radiation in stage I-IIIA disease divided respondents within both specialties. Chemotherapy plus radiation vs radiation alone in unresectable stage IIIA-B NSCLC was viewed as benefiting survival less often by physicians seeing < 10 lung cancer patients annually rather than > 25 (57% vs 0.77%, respectively) and by physicians underestimating rather than correctly estimating survival in early-stage disease (58% vs 0.72%, respectively). Chemotherapy was believed to confer survival benefits in patients with stage IV disease by one third of respondents.
Certain physician characteristics, particularly the length of time since training and NSCLC patient volume, are associated with beliefs not conclusively supported in the medical literature or with opinions inconsistent within and between specialties.</description><identifier>ISSN: 0012-3692</identifier><identifier>EISSN: 1931-3543</identifier><identifier>DOI: 10.1378/chest.118.1.129</identifier><identifier>PMID: 10893370</identifier><identifier>CODEN: CHETBF</identifier><language>eng</language><publisher>Northbrook, IL: Elsevier Inc</publisher><subject>Adult ; Attitude of Health Personnel ; attitudes ; Biological and medical sciences ; carcinoma ; Carcinoma, Non-Small-Cell Lung - mortality ; Carcinoma, Non-Small-Cell Lung - surgery ; Carcinoma, Non-Small-Cell Lung - therapy ; clinical practice patterns ; Combined Modality Therapy ; Female ; Humans ; Lung cancer ; Lung Neoplasms - mortality ; Lung Neoplasms - surgery ; Lung Neoplasms - therapy ; Male ; Medical sciences ; Middle Aged ; non-small cell physician knowledge ; physician surveys ; practice ; Practice Patterns, Physicians ; Pulmonary Medicine ; Referral and Consultation ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the respiratory system ; Thoracic Surgery</subject><ispartof>Chest, 2000-07, Vol.118 (1), p.129-137</ispartof><rights>2000 The American College of Chest Physicians</rights><rights>2000 INIST-CNRS</rights><rights>Copyright American College of Chest Physicians Jul 2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-58084f57560469b7b66e970ab88789407586274bdb00f5c8125d7e96e677f9833</citedby><cites>FETCH-LOGICAL-c439t-58084f57560469b7b66e970ab88789407586274bdb00f5c8125d7e96e677f9833</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1436630$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10893370$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schroen, Anneke T.</creatorcontrib><creatorcontrib>Detterbeck, Frank C.</creatorcontrib><creatorcontrib>Crawford, Robert</creatorcontrib><creatorcontrib>Rivera, M. Patricia</creatorcontrib><creatorcontrib>Socinski, Mark A.</creatorcontrib><title>Beliefs Among Pulmonologists and Thoracic Surgeons in the Therapeutic Approach to Non-small Cell Lung Cancer</title><title>Chest</title><addtitle>Chest</addtitle><description>The physicians who initially evaluate patients with non-small cell lung cancer (NSCLC) strongly impact the course of therapy. Their beliefs in treatment and prognosis may contribute to practices of variable quality and appropriateness. We sought to better describe beliefs among pulmonologists and thoracic surgeons who were selected for guiding early therapy and referrals in patients with NSCLC.
Mail questionnaire focusing on survival estimates, treatment perceptions, and referral patterns.
Twelve hundred pulmonologists and 800 thoracic surgeons who were clinically active members of the American College of Chest Physicians.
Response rates of 50% for pulmonologists and 52% for thoracic surgeons were obtained after two mailings. Five-year survival estimates for patients with resected stage I NSCLC revealed that 30% of respondents overestimated survival rates and 18% underestimated survival rates. The underestimation of survival rate was found among more respondents who are practicing pulmonology than thoracic surgery (22% vs 0.10%, respectively), who were trained before 1980 than after 1980 (29% vs 0.10%, respectively), and who were seeing < 10 lung cancer patients annually than those who were seeing > 25 (31% vs 0.14%, respectively). Beliefs in the survival benefit of adjuvant chemotherapy or of radiation in stage I-IIIA disease divided respondents within both specialties. Chemotherapy plus radiation vs radiation alone in unresectable stage IIIA-B NSCLC was viewed as benefiting survival less often by physicians seeing < 10 lung cancer patients annually rather than > 25 (57% vs 0.77%, respectively) and by physicians underestimating rather than correctly estimating survival in early-stage disease (58% vs 0.72%, respectively). Chemotherapy was believed to confer survival benefits in patients with stage IV disease by one third of respondents.
Certain physician characteristics, particularly the length of time since training and NSCLC patient volume, are associated with beliefs not conclusively supported in the medical literature or with opinions inconsistent within and between specialties.</description><subject>Adult</subject><subject>Attitude of Health Personnel</subject><subject>attitudes</subject><subject>Biological and medical sciences</subject><subject>carcinoma</subject><subject>Carcinoma, Non-Small-Cell Lung - mortality</subject><subject>Carcinoma, Non-Small-Cell Lung - surgery</subject><subject>Carcinoma, Non-Small-Cell Lung - therapy</subject><subject>clinical practice patterns</subject><subject>Combined Modality Therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - mortality</subject><subject>Lung Neoplasms - surgery</subject><subject>Lung Neoplasms - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>non-small cell physician knowledge</subject><subject>physician surveys</subject><subject>practice</subject><subject>Practice Patterns, Physicians</subject><subject>Pulmonary Medicine</subject><subject>Referral and Consultation</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the respiratory system</subject><subject>Thoracic Surgery</subject><issn>0012-3692</issn><issn>1931-3543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kd-L1DAQx4Mo3nr67JsEkXvrXtK0-fG4t3gqLCp4Poc0nW5zdJs1aRX_e8ftwh2CLxnCfOY7X75DyGvO1lwofe17yNOac73ma16aJ2TFjeCFqCvxlKwY42UhpCkvyIuc7xn-uZHPyQVn2gih2IoMNzAE6DLdHOK4p1_nAWsc4j7kKVM3tvSuj8n54Om3Oe0hjpmGkU49YAOSO8I8YW9zPKbofE-nSD_HscgHNwx0C_jsZtTdutFDekmedW7I8OpcL8n32_d324_F7suHT9vNrvCVMFNRa6arrla1ZJU0jWqkBKOYa7RW2lRM1VqWqmrahrGu9pqXdavASJBKdUYLcUmuFl009WPGhOwhZI9m3AhxzlbxUpRVaRB8-w94H-c0ojdbMlYpXCgRul4gn2LOCTp7TOHg0m_Lmf17BXu6gsUrWG75SfbNWXZuDtA-4pfYEXh3Blz2bugSxhPyA1cJKQV72NyHff8rJLCnXFFVLDvPbh9vNssEYLw_AySbfQDMvsVpP9k2hv-6_gOxZ7Nq</recordid><startdate>20000701</startdate><enddate>20000701</enddate><creator>Schroen, Anneke T.</creator><creator>Detterbeck, Frank C.</creator><creator>Crawford, Robert</creator><creator>Rivera, M. Patricia</creator><creator>Socinski, Mark A.</creator><general>Elsevier Inc</general><general>American College of Chest Physicians</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20000701</creationdate><title>Beliefs Among Pulmonologists and Thoracic Surgeons in the Therapeutic Approach to Non-small Cell Lung Cancer</title><author>Schroen, Anneke T. ; Detterbeck, Frank C. ; Crawford, Robert ; Rivera, M. Patricia ; Socinski, Mark A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-58084f57560469b7b66e970ab88789407586274bdb00f5c8125d7e96e677f9833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adult</topic><topic>Attitude of Health Personnel</topic><topic>attitudes</topic><topic>Biological and medical sciences</topic><topic>carcinoma</topic><topic>Carcinoma, Non-Small-Cell Lung - mortality</topic><topic>Carcinoma, Non-Small-Cell Lung - surgery</topic><topic>Carcinoma, Non-Small-Cell Lung - therapy</topic><topic>clinical practice patterns</topic><topic>Combined Modality Therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - mortality</topic><topic>Lung Neoplasms - surgery</topic><topic>Lung Neoplasms - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>non-small cell physician knowledge</topic><topic>physician surveys</topic><topic>practice</topic><topic>Practice Patterns, Physicians</topic><topic>Pulmonary Medicine</topic><topic>Referral and Consultation</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the respiratory system</topic><topic>Thoracic Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schroen, Anneke T.</creatorcontrib><creatorcontrib>Detterbeck, Frank C.</creatorcontrib><creatorcontrib>Crawford, Robert</creatorcontrib><creatorcontrib>Rivera, M. Patricia</creatorcontrib><creatorcontrib>Socinski, Mark A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Chest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schroen, Anneke T.</au><au>Detterbeck, Frank C.</au><au>Crawford, Robert</au><au>Rivera, M. Patricia</au><au>Socinski, Mark A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Beliefs Among Pulmonologists and Thoracic Surgeons in the Therapeutic Approach to Non-small Cell Lung Cancer</atitle><jtitle>Chest</jtitle><addtitle>Chest</addtitle><date>2000-07-01</date><risdate>2000</risdate><volume>118</volume><issue>1</issue><spage>129</spage><epage>137</epage><pages>129-137</pages><issn>0012-3692</issn><eissn>1931-3543</eissn><coden>CHETBF</coden><abstract>The physicians who initially evaluate patients with non-small cell lung cancer (NSCLC) strongly impact the course of therapy. Their beliefs in treatment and prognosis may contribute to practices of variable quality and appropriateness. We sought to better describe beliefs among pulmonologists and thoracic surgeons who were selected for guiding early therapy and referrals in patients with NSCLC.
Mail questionnaire focusing on survival estimates, treatment perceptions, and referral patterns.
Twelve hundred pulmonologists and 800 thoracic surgeons who were clinically active members of the American College of Chest Physicians.
Response rates of 50% for pulmonologists and 52% for thoracic surgeons were obtained after two mailings. Five-year survival estimates for patients with resected stage I NSCLC revealed that 30% of respondents overestimated survival rates and 18% underestimated survival rates. The underestimation of survival rate was found among more respondents who are practicing pulmonology than thoracic surgery (22% vs 0.10%, respectively), who were trained before 1980 than after 1980 (29% vs 0.10%, respectively), and who were seeing < 10 lung cancer patients annually than those who were seeing > 25 (31% vs 0.14%, respectively). Beliefs in the survival benefit of adjuvant chemotherapy or of radiation in stage I-IIIA disease divided respondents within both specialties. Chemotherapy plus radiation vs radiation alone in unresectable stage IIIA-B NSCLC was viewed as benefiting survival less often by physicians seeing < 10 lung cancer patients annually rather than > 25 (57% vs 0.77%, respectively) and by physicians underestimating rather than correctly estimating survival in early-stage disease (58% vs 0.72%, respectively). Chemotherapy was believed to confer survival benefits in patients with stage IV disease by one third of respondents.
Certain physician characteristics, particularly the length of time since training and NSCLC patient volume, are associated with beliefs not conclusively supported in the medical literature or with opinions inconsistent within and between specialties.</abstract><cop>Northbrook, IL</cop><pub>Elsevier Inc</pub><pmid>10893370</pmid><doi>10.1378/chest.118.1.129</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0012-3692 |
ispartof | Chest, 2000-07, Vol.118 (1), p.129-137 |
issn | 0012-3692 1931-3543 |
language | eng |
recordid | cdi_proquest_miscellaneous_71232429 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adult Attitude of Health Personnel attitudes Biological and medical sciences carcinoma Carcinoma, Non-Small-Cell Lung - mortality Carcinoma, Non-Small-Cell Lung - surgery Carcinoma, Non-Small-Cell Lung - therapy clinical practice patterns Combined Modality Therapy Female Humans Lung cancer Lung Neoplasms - mortality Lung Neoplasms - surgery Lung Neoplasms - therapy Male Medical sciences Middle Aged non-small cell physician knowledge physician surveys practice Practice Patterns, Physicians Pulmonary Medicine Referral and Consultation Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the respiratory system Thoracic Surgery |
title | Beliefs Among Pulmonologists and Thoracic Surgeons in the Therapeutic Approach to Non-small Cell Lung Cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T23%3A54%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Beliefs%20Among%20Pulmonologists%20and%20Thoracic%20Surgeons%20in%20the%20Therapeutic%20Approach%20to%20Non-small%20Cell%20Lung%20Cancer&rft.jtitle=Chest&rft.au=Schroen,%20Anneke%20T.&rft.date=2000-07-01&rft.volume=118&rft.issue=1&rft.spage=129&rft.epage=137&rft.pages=129-137&rft.issn=0012-3692&rft.eissn=1931-3543&rft.coden=CHETBF&rft_id=info:doi/10.1378/chest.118.1.129&rft_dat=%3Cproquest_cross%3E71232429%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=200478876&rft_id=info:pmid/10893370&rft_els_id=S0012369215390139&rfr_iscdi=true |